ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer

Lin, Zhoujun; Li, Yin; Han, Xiao; Fu, Zhenkun; Tian, Zhenhuan*; Li, Chenggang*南开大学; 哈尔滨医科大学; 中国医学科学院北京协和医院; 1
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES2022-11DOI: 10.3390/ijms232112741
3被引5阅读
引用收藏
分享

摘要

Non-small cell lung cancer (NSCLC) accounts for 85 similar to 90% of lung cancer cases, with a poor prognosis and a low 5-year survival rate. Sphingosine kinase-1 (SPHK1), a key enzyme in regulating sphingolipid metabolism, has been reported to be involved in the development of NSCLC, although the underlying mechanism remains unclear. In the present study, we demonstrated the abnormal signature of SPHK1 in NSCLC lesions and cell lines of lung cancers with a potential tumorigenic role in cell cycle regulation. Functionally, ectopic Pre-B cell leukemia homeobox-1 (PBX1) was capable of restoring the arrested G1 phase induced by SPHK1 knockdown. However, exogenous sphingosine-1-phosphate (S1P) supply had little impact on the cell cycle arrest by PBX1 silence. Furthermore, S1P receptor S1PR3 was revealed as a specific switch to transport the extracellular S1P signal into cells, and subsequently activated PBX1 to regulate cell cycle progression. In addition, Akt signaling partially participated in the SPHK1/S1PR3/PBX1 axis to regulate the cell cycle, and the Akt inhibitor significantly decreased PBX1 expression and induced G1 arrest. Targeting SPHK1 with PF-543 significantly inhibited the cell cycle and tumor growth in preclinical xenograft tumor models of NSCLC. Taken together, our findings exhibit the vital role of the SPHK1/S1PR3/PBX1 axis in regulating the cell cycle of NSCLC, and targeting SPHK1 may develop a therapeutic effect in tumor treatment.

学科与关键词

关键词
non-small cell lung cancerSPHK1PBX1S1PR3cell cycle
相关
加载中…
  • Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI3K/Akt/NF-kappa B Pathway in Human Non-Small Cell Lung Cancer
    Song Libing*; Xiong Huaping; Li Jun; Liao Wenting; Wang Lan; Wu Jueheng; Li MengfengClinical Cancer Research, 2011, 17(7): 1839-1849.被引 62
  • Overexpression of SPHK1 associated with targeted therapy resistance in predicting poor prognosis in renal cell carcinoma
    Bao, Ji-Ming*; Zhi, Xi; Yuan, Hao-Yu; Chen, Tao-Yi; Chen, Ming-Kun; Zhou, Jun-Hao; Xue, Kang-Yi; Yang, Jian-Kun*; Liu, Cun-Dong*Translational Cancer Research, 2023, 12(3): 572-584.
  • Targeting SPHK1/S1PR3-regulated S-1-P metabolic disorder triggers autophagic cell death in pulmonary lymphangiomyomatosis (LAM)
    Li, Fei; Zhang, Yifan; Lin, Zhoujun; Yan, Lizhong; Liu, Qiao; Li, Yin; Pei, Xiaolin; Feng, Ya; Han, Xiao; Yang, Juan; Zheng, Fangxu; Li, Tianjiao; Zhang, Yupeng; Fu, Zhenkun; Shao, Di*; Yu, Jane*; Li, Chenggang*Cell Death & Disease, 2022, 13(12): 1065.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
发表日期
2022-11
卷期
第 23 卷, 第 21 期
页码
12741
DOI
10.3390/ijms232112741
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Fundamental Research Funds for the Central Universities, Nankai University [ZB19100128]; Tianjin Natural Science Foundation [18JCYBJC40700]; LAM China Non-profit Organization Special Fund for LAM of Zhejiang Women and Children's Foundation [LAM001-202205]

作者

  • L

    Lin, Zhoujun (第一作者)

    nankai univ

  • L

    Li, Yin

    nankai univ

查看全部 6 位作者收起作者
  • H

    Han, Xiao

    nankai univ

  • F

    Fu, Zhenkun

    nankai univ · harbin med univ

  • T

    Tian, Zhenhuan (通讯)

    1 · peking union med coll hosp

  • L

    Li, Chenggang (通讯)

    nankai univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417